Supplementary Functional Annotation description
To further prioritize likely causal variants and generate testable functional hypotheses about the underlying mechanisms, a bioinformatics framework was used to query publicly available biological datasets (see Table G Regional plot of the MTHFR/CLCN6 region in African American samples using LD based on the 1000G European ancestry sample (EUR). The most significant SNP at this locus, rs56153133 (CLCN6, purple star), is in high LD with the GWAS SNP rs17367504 (MTHFR) in 1000G EUR. However, this SNP was not significantly associated with diastolic BP in PAGE African Americans, suggesting that it may not be the causal variant (if it is assumed that the causal variant is common to multiple ancestral groups).
rs17367504 Figure D. Fine-mapping regional plots of 15q26.1 SBP Locus in African Americans
SNPs in both Locus Zoom plots reflect AA p-values. LD between the previously reported GWAS SNP, rs2521501/FES (purple star) and other SNPs is shown based on European (panel A) and African (plot B) ancestries. Rs2521501/FES is in high LD in 1000G EUR (r 2 >0.6) with several SNPs shown in red and orange (panel A), which may make it difficult to know which SNP is driving the signal in EUR. LD across the region is reduced in AA and rs2521501/FES is in modest LD with only a few SNPs in AA (r 2 >0.4) and none are even nominally significant in AA (panel B). In AA, the best markers in this region are the FURIN intronic SNPs, rs6224 and rs17514846, and rs116516152 (7.7kb 5' of FURIN); none are strongly correlated with the GWAS SNP in AA, which could suggest that rs2521501/FES (purple star) is less likely to be the functional SNP. Plot of the HOTTIP region using p-values from the trans-ethnic analysis (fixed effects model) and LD based on the 1000G EUR sample. The most significant SNP at this locus, rs2023843 (HOTTIP/intron, purple star), is in high LD with other HOTTIP SNPs and in modest LD with a few neighbouring SNPs in EVX1 and the HOXA genes. The GWAS SNPs previously reported in African ancestry samples (rs17428471, rs17471520, and rs11564022) located downstream from EVX1 were not available on the Metabochip, and are not shown. However, LD between rs2023843 and a) rs17428471 or b) rs17471520 is low in both 1000G EUR and AFR, r 2 <0.03.
LD between rs2023843 and rs11564022 is higher in 1000G AFR, r 2 =0.27; it is unclear whether these two SNPs reflect the same signal.
Figure F. Trans-ethnic results: fine mapping regional plots of the SBP FGF5 Locus
Regional plot of the FGF5 region using p-values from the trans-ethnic analysis (fixed effects model) and LD based on the 1000G EUR sample. The most significant trans-ethnic SNP at this locus, rs13125101 (purple diamond), is in high LD with the prior GWAS SNPs rs16998073 and rs11099098 (shown in grey text), and with rs1458038, the top SNP in PAGE Hispanics. It is also in high LD with a novel intronic FGF5 SNP, rs36034102 and a few neighbouring SNPs in the 5`region of FGF5.
SUPPLEMENTAL METHODS A Study Description and Blood Pressure Measurements

PAGE and FBPP Studies
The ARIC is a multi-center cohort of predominantly white and African Americans [5] . ARIC BP lowering medication use was recorded from the medication history.
WHI is a prospective study investigating post-menopausal women's health [6, 7] . A total of 161, 808 women aged 50-79 years old were recruited from 40 U.S. clinical centers between 1993 and 1998 to participate in an observational study and clinical trials. Socio-demographic characteristics, lifestyle factors, medical history, medication use and physical measures of height, weight, and blood pressure, were collected at the baseline visit. BP was measured by certified staff using standardized procedures and instruments. Two BP measures were recorded after 5 minutes rest using a mercury sphygmomanometer, and the average of the two measurements was used in analyses. Appropriate cuff bladder size was determined at each visit based on arm circumference. Diastolic BP was taken from the phase V Korotkoff measures. A total of 5,155
Hispanics and 11,653 African American from WHI with genetic data were included in this analysis.
CARDIA is a population based, prospective cohort examining the development and determinants of clinical and subclinical cardiovascular disease and its risk factors, which and Oakland, CA [8] . Baseline measurements were repeated, and additional measurements Framingham, MA; Minneapolis, MN; and Salt Lake City, UT. Study participants were recruited as one of three main types of subjects: 1) as part of a hypertensive sibship with at least two siblings diagnosed with hypertension; 2) random subjects, who were age-matched with hypertensive sibs; or 3) unmedicated adult offspring of one or more of the hypertensive siblings.
Preference in ascertainment and recruitment was given to hypertensive sibships in which at least one of the subjects was classified as having severe hypertension. BP was measured using an automated oscillometric BP measurement device with a consistent protocol across the FBPP networks. Two or three BP measures were averaged. measurements on all MESA participants at baseline. After a 5-minute rest, BP was measured on seated subjects 3 times at 1-minute intervals using the Dinamap PRO 100 automated oscillometric device (Critikon, Tampa, FL) with the back and arm supported. The average of the second and third BP readings was used for analysis.
In addition to the Metabochip, participants in the original MESA cohort, the MESA Family Study and the MESA Air Pollution Study who consented to genetic analyses were genotyped in 2009 using the Affymetrix Human SNP array 6.0. Genotype quality control for these data included exclusion filters on SNP level call rate < 95%, individual level call rate < 95%, and heterozygosity > 53% as described previously [14] . The cleaned genotypic data was deposited with MESA phenotypic data into dbGaP as the MESA SHARe project (study accession phs000209, http://www.ncbi.nlm.nih.gov/projects/gap/cgibin/study.cgi?study_id=phs000209.v7.p2); 8,224 consenting individuals (2,685 White, 2,588 non-Hispanic African-American, 2,174 Hispanic, 777 Chinese) were included, with 897,981
SNPs passing study specific quality control (QC). For GWAS, IMPUTE version 2.1.0 was used to perform imputation (chromosomes 1-22) using HapMap Phase I and II -CEU+YRI+CHB+JPT as the reference panel (release #22 -NCBI Build 36 (dbSNP b126)) (only the CEU reference panel was used for imputation in Whites). IMPUTE version 2.2.2 was used to perform imputation for the MESA SHARe participants using the cosmopolitan 1,000
Genomes Phase 1 v3 March 2012 reference set.
